Antiphospholipid Syndrome Date: Tue, Feb 28th, 2023 Time: 8:00 am - 9:00 am Location: Online
Speaker:
Doruk Erkan, MD, MPH Disclosures: Dr. Erkan received Grant/Research/Clinical Trial Support from ACR & European League Against Rheumatism, Exagen, Immune Tolerance Network via NIH-NIAID, Lupus Clinical Trials Consortium; Consultant/on the Advisory Boards for Chugai Pharmaceuticals; On the Speaker’s Bureau for GlaxoSmithKline, Aurinia; Receives Royalties from Up-To-Date
> Understand the spectrum of Antiphospholipid Syndrome (APS).
> Understand the diagnostic utility of antiphospholipid antibody (aPL) tests.
> Discuss the management of persistently aPL-positive patients with different aPL-related clinical manifestation.
Accreditation
NewYork Presbyterian/Queens is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians.
NewYork Presbyterian/Queens designates this Live Activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement
The Medical Society of The State of New York relies upon planners and faculty participants in its CME activities to provide educational information that is objective and free of bias. In this spirit and in accordance with the guidelines of MSSNY, CPME and the ACCME, all speakers and planners for CME activities must disclose any relevant financial relationships with
commercial interests whose products, devices or services may be discussed in the content of a CME activity, that might be perceived as a real or apparent conflict of interest. Any discussion of investigational or unlabeled uses of a product will be identified.